ADA: Screen All With Type 2 Diabetes for Fatty Liver Disease
A new update to the American Diabetes Associations Standards of Care advises use of the fibrosis-4 (FIB-4) index for screening and use of GLP-1 agonists or pioglitazone for treatment.
United States Scott Isaacs Novo Nordisk American Association Of Clinical Endocrinology American Diabetes Association University Of Florida
Source: medscape.com